Severine Vermeire
Molecular Biology · 2003–2021
A researcher in the Science corpus: 30 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 134 citations into it
- Surgery — 79 citations into it
- Gastroenterology — 25 citations into it
- Neurology — 21 citations into it
- Oncology — 18 citations into it
- Food Science — 17 citations into it
Whom Severine Vermeire trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- J. Turner (in Surgery)
- Emeran A. Mayer (in Gastroenterology)
- A. Fasano (in Surgery)
- D. Huh (in Biomedical Engineering)
- H. Flint (in Molecular Biology)
Papers from Severine Vermeire's perspective
Ordered by how strongly the researchers Severine Vermeire trusts endorse each paper. Same corpus, a different order for every researcher.
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis (Gut)
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease (Nature)
- Intestinal mucosal barrier function in health and disease (Nature reviews. Immunology)
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity (Proceedings of the National Academy of Sciences of the United States of America)
- Intestinal barrier function: molecular regulation and disease pathogenesis. (Journal of Allergy and Clinical Immunology)
- Intestinal permeability – a new target for disease prevention and therapy (BMC Gastroenterology)
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (Science)
- Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation (Nature)
- Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. (Science)
- Bifidobacteria can protect from enteropathogenic infection through production of acetate (Nature)
Their papers
- A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis (2013) — 1,715 citations
- Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives (2011) — 1,065 citations
- Quantitative microbiome profiling links gut community variation to microbial load (2017) — 1,043 citations
- Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (2011) — 1,319 citations
- Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. (2005) — 963 citations
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death (2003) — 904 citations
- A microbial signature for Crohn's disease (2017) — 770 citations
- Short chain fatty acids and its producing organisms: An overlooked therapy for IBD? (2021) — 627 citations
- Fine-mapping inflammatory bowel disease loci to single variant resolution (2017) — 540 citations
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis (2017) — 877 citations
- The intestinal barrier: a fundamental role in health and disease (2017) — 1,120 citations
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study (2016) — 690 citations
- Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. (2016) — 1,455 citations
- Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease. (2015) — 847 citations
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease (2012) — 810 citations
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. (2012) — 890 citations
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. (2012) — 1,275 citations
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. (2010) — 930 citations
- Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. (2010) — 777 citations
- Meta-Analysis Increases to 71 the Tally of Confirmed Crohn’s Disease Susceptibility Loci (2010) — 2,611 citations